Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,707
Out of 5,154 analysts
15
Total ratings
9.09%
Success rate
-38.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley | Initiates: Buy | $18 | $3.39 | +430.97% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $22.16 | -23.29% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $6.58 | +416.72% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $162.33 | -41.48% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.30 | -13.04% | 2 | May 20, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $0.90 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $4.80 | +566.67% | 4 | Dec 16, 2020 |
AtaiBeckley
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $3.39
Upside: +430.97%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $22.16
Upside: -23.29%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $6.58
Upside: +416.72%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $162.33
Upside: -41.48%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.30
Upside: -13.04%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.90
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $4.80
Upside: +566.67%